CureCervicalCancer (Kenya)
CureCervicalCancer (CCC) is a non-profit organisation dedicated to eliminating cervical cancer in low-resource settings through early detection and prevention. Registered in the US and Kenya, CCC has screened over 213,000 women globally, treated more than 16,000, and trained over 3,700 healthcare workers since its inception. Its innovative model brings life-saving care directly to women in underserved communities by combining home-based HPV self-sample testing, mobile treatment clinics, and digital health tools. CCC’s mission is to create scalable, equitable solutions that strengthen health systems and save lives.
In 2025-2026, the Eurofins Foundation is supporting the project “Mobile Health for Mamas (HPV Testing & Treatment for Women in Kenya).” This initiative aims to deliver cervical cancer prevention services to women in remote and marginalised areas of Kenya, where access to screening and treatment remains critically low.
Cervical cancer is nearly 100% preventable, yet it is the leading cause of cancer-related deaths among Kenyan women, and most women have never been screened. Barriers such as distance, cost, stigma, and limited health infrastructure mean that most women do not seek care until symptoms appear, when treatment options are limited and outcomes are poor. The Mobile Health for Mamas programme was launched to close these gaps by bringing WHO-endorsed HPV testing and same-day treatment directly into communities, ensuring timely and dignified care.
The project will screen 38,000 women in 2026, including 1,500 women supported by the Eurofins Foundation grant. The funding will cover HPV test kits, mobile treatment clinics, training for 51 local healthcare workers, and community education campaigns. It will also support digital patient tracking systems to ensure continuity of care. By strengthening diagnostic systems, expanding lab and digital capacity and improving operational efficiency, the project will reach more women faster, and move Kenya closer to the global goal of eliminating cervical cancer.
This project contributes to the following United Nations' Sustainable Development Goals
